David A. Herold

2.5k total citations
79 papers, 1.8k citations indexed

About

David A. Herold is a scholar working on Spectroscopy, Analytical Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David A. Herold has authored 79 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Spectroscopy, 15 papers in Analytical Chemistry and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David A. Herold's work include Analytical chemistry methods development (14 papers), Mass Spectrometry Techniques and Applications (11 papers) and Analytical Chemistry and Chromatography (10 papers). David A. Herold is often cited by papers focused on Analytical chemistry methods development (14 papers), Mass Spectrometry Techniques and Applications (11 papers) and Analytical Chemistry and Chromatography (10 papers). David A. Herold collaborates with scholars based in United States, Germany and Taiwan. David A. Herold's co-authors include David E. Bruns, Robert L. Fitzgerald, Michael Kinter, Suresh K. Aggarwal, Peter D. Reaven, Joellen Barnett, Steve Edelman, Wendy L. Frankel, Thomas W. Ziegler and Daniel A. Spyker and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Chemistry and Diabetes Care.

In The Last Decade

David A. Herold

79 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David A. Herold 394 369 190 175 170 79 1.8k
David J. Berry 668 1.7× 355 1.0× 285 1.5× 224 1.3× 90 0.5× 98 4.7k
Chi Tim Hung 481 1.2× 324 0.9× 277 1.5× 253 1.4× 438 2.6× 116 2.5k
Reza Mehvar 766 1.9× 661 1.8× 312 1.6× 300 1.7× 345 2.0× 143 3.4k
Isabel González‐Álvarez 732 1.9× 213 0.6× 288 1.5× 185 1.1× 282 1.7× 143 3.2k
Masahiro Nakano 388 1.0× 128 0.3× 189 1.0× 146 0.8× 372 2.2× 247 2.8k
Dario Voinovich 505 1.3× 342 0.9× 286 1.5× 193 1.1× 240 1.4× 105 3.0k
Satomi Onoue 1.4k 3.5× 355 1.0× 351 1.8× 269 1.5× 476 2.8× 220 5.5k
Ryuichi Hasegawa 1.1k 2.8× 75 0.2× 157 0.8× 76 0.4× 46 0.3× 147 4.4k
Anwar Hussain 459 1.2× 283 0.8× 100 0.5× 139 0.8× 70 0.4× 93 1.9k
Marival Bermejo 1.0k 2.6× 599 1.6× 301 1.6× 447 2.6× 310 1.8× 143 4.6k

Countries citing papers authored by David A. Herold

Since Specialization
Citations

This map shows the geographic impact of David A. Herold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Herold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Herold more than expected).

Fields of papers citing papers by David A. Herold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Herold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Herold. The network helps show where David A. Herold may publish in the future.

Co-authorship network of co-authors of David A. Herold

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Herold. A scholar is included among the top collaborators of David A. Herold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Herold. David A. Herold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yun, Yeo‐Min, et al.. (2012). Dilute and Shoot: Analysis of Drugs of Abuse Using Selected Reaction Monitoring for Quantification and Full Scan Product Ion Spectra for Identification. Journal of Analytical Toxicology. 36(2). 106–111. 25 indexed citations
2.
Fitzgerald, Robert L., et al.. (2009). Analysis of Testosterone in Serum Using Mass Spectrometry. Methods in molecular biology. 603. 489–500. 11 indexed citations
3.
Lu, Chuanyi M., et al.. (2008). Measurement of Microalbuminuria Using Protein Chip Electrophoresis. American Journal of Clinical Pathology. 129(3). 432–438. 12 indexed citations
4.
Herold, David A., et al.. (2007). Interference With Hemoglobin A1cDetermination by the Hemoglobin Variant Shelby. American Journal of Clinical Pathology. 128(3). 440–444. 4 indexed citations
5.
Bouvet, Michael, et al.. (2006). CAUSES OF HYPERCALCEMIA IN A POPULATION OF MILITARY VETERANS IN THE UNITED STATES. Endocrine Practice. 12(5). 535–541. 9 indexed citations
6.
Huang, Lei, Jerald S. Feitelson, Kosi Gramatikoff, et al.. (2005). Immunoaffinity separation of plasma proteins by IgY microbeads: Meeting the needs of proteomic sample preparation and analysis. PROTEOMICS. 5(13). 3314–3328. 138 indexed citations
7.
Fitzgerald, Robert L. & David A. Herold. (1997). Improved CEDIA® Benzodiazepine Assay Eliminates Sertraline Crossreactivity. Journal of Analytical Toxicology. 21(1). 32–35. 11 indexed citations
8.
Fitzgerald, Robert L., et al.. (1996). Current Techniques in Mycobacterial Detection and Speciation. Critical Reviews in Clinical Laboratory Sciences. 33(2). 83–138. 13 indexed citations
9.
Frankel, Wendy L., David A. Herold, Thomas W. Ziegler, & Robert L. Fitzgerald. (1996). Cardiac Troponin T Is Elevated in Asymptomatic Patients With Chronic Renal Failure. American Journal of Clinical Pathology. 106(1). 118–123. 97 indexed citations
10.
Aggarwal, Suresh K., Michael Kinter, Robert L. Fitzgerald, David A. Herold, & W. W. Harrison. (1994). Mass Spectrometry of Trace Elements in Biological Samples. Critical Reviews in Clinical Laboratory Sciences. 31(1). 35–87. 13 indexed citations
12.
Aggarwal, Suresh K., Robert G. Orth, Jay M. Wendling, Michael Kinter, & David A. Herold. (1993). Isotope Dilution Gas Chromatography/Mass Spectrometry for Cadmium Determination in Urine. Journal of Analytical Toxicology. 17(1). 5–10. 5 indexed citations
13.
Fitzgerald, Robert L., et al.. (1993). Benzodiazepine Analysis by Negative Chemical Ionization Gas Chromatography/Mass Spectrometry. Journal of Analytical Toxicology. 17(6). 342–347. 41 indexed citations
14.
Aggarwal, Suresh K., Michael Kinter, & David A. Herold. (1992). Determination of cobalt in urine by gas chromatography—mass spectrometry employing nickel as an internal standard. Journal of Chromatography B Biomedical Sciences and Applications. 576(2). 297–304. 14 indexed citations
16.
Lettieri, John, et al.. (1991). Lidocaine Diffusion in Five Tissue Expanders: An In Vitro and In Vivo Study. Annals of Plastic Surgery. 27(4). 312–315. 2 indexed citations
17.
Lettieri, John, et al.. (1991). Steroid and Benzyl Alcohol Diffusion Through Tissue Expanders and Double Lumen Breast Implants. Annals of Plastic Surgery. 27(4). 316–320. 5 indexed citations
18.
Aggarwal, Suresh K., Michael Kinter, M. R. Wills, John Savory, & David A. Herold. (1990). Determination of chromium in urine by stable isotope dilution gas chromatography/mass spectrometry using lithium bis(trifluoroethyl)dithiocarbamate as a chelating agent. Analytical Chemistry. 62(2). 111–115. 24 indexed citations
19.
Herold, David A., et al.. (1989). Oxidation of polyethylene glycols by alcohol dehydrogenase. Biochemical Pharmacology. 38(1). 73–76. 334 indexed citations
20.
Herold, David A., et al.. (1989). Measurement of plasma thromboxane B2 by gas chromatography—mass spectrometry using 18O2-labelled thromboxane B2 as the internal standard. Journal of Chromatography B Biomedical Sciences and Applications. 496(1). 180–188. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026